RECRUITING · INTERVENTIONAL · TREATMENT study · Squamous Cell Carcinoma of the Head and Neck · Phase 2 · Enrollment 70 · Sponsor: National Cancer Institute (NCI)
ClinicalTrials.gov published a clinical update in Oncology on 27 Mar 2026. The item focuses on Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer. Open the detail page to review the full original feed content.